NCT06030973

Brief Summary

The goal of this online survey is to gain further insights in the needs and burden for a European registry for neuromodulation, according to healthcare providers.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Aug 2023

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 26, 2023

Completed
5 days until next milestone

Study Start

First participant enrolled

August 31, 2023

Completed
2 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 2, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 2, 2023

Completed
9 days until next milestone

First Posted

Study publicly available on registry

September 11, 2023

Completed
Last Updated

September 11, 2023

Status Verified

September 1, 2023

Enrollment Period

2 days

First QC Date

August 26, 2023

Last Update Submit

September 2, 2023

Conditions

Outcome Measures

Primary Outcomes (4)

  • Healthcare providers their current degree of participation in a registry for neuromodulation.

    Degree of participation in a registry for neuromodulation (question).

    Cross-sectional evaluation during 3th Joint Congress of the INS European Chapters (e-INS 2023) in Hamburg in August-September 2023.

  • Healthcare providers their need for a European registry.

    Underlying reasons on why a European registry is needed, or not needed (question).

    Cross-sectional evaluation during 3th Joint Congress of the INS European Chapters (e-INS 2023) in Hamburg in August-September 2023.

  • Items that should be included in a registry for neuromodulation, according to healthcare providers.

    Items that should be collection within a registry, evaluated with a multiple choice question.

    Cross-sectional evaluation during 3th Joint Congress of the INS European Chapters (e-INS 2023) in Hamburg in August-September 2023.

  • Access regulations to European registry for neuromodulation, according to healthcare providers.

    Access regulations, evaluated with a multiple choice question.

    Cross-sectional evaluation during 3th Joint Congress of the INS European Chapters (e-INS 2023) in Hamburg in August-September 2023.

Study Arms (1)

Healthcare professionals involved in neuromodulation

Behavioral: Filling in an online survey

Interventions

Professionals are asked to complete questions regarding 1) the degree of current participation in a registry, 2) the need for a European registry, 3) the items that should be collected and 4) access to the European registry.

Healthcare professionals involved in neuromodulation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

In this study male and female adults who are involved in the management of chronic pain and more specifically in neuromodulation for pain (including but not limited to anesthesiologists, neurosurgeons, nurses) will be eligible to complete the survey. The survey will be spread at the 3ʳᵈ Joint Congress of the INS European Chapters (e-INS 2023) in Hamburg from 31/8/2023 to 2/9/2023.

You may qualify if:

  • Male and female adults who are involved in the management of chronic pain and more specifically in neuromodulation for pain (including but not limited to anesthesiologists, neurosurgeons, nurses).

You may not qualify if:

  • Not involved in management of chronic pain through neuromodulation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Congres Center

Hamburg, Germany

RECRUITING

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

August 26, 2023

First Posted

September 11, 2023

Study Start

August 31, 2023

Primary Completion

September 2, 2023

Study Completion

September 2, 2023

Last Updated

September 11, 2023

Record last verified: 2023-09

Locations